Recently, it has become apparent that superficial vein thrombosis (SVT) can have serious complications. However, themagnitude of the risk of subsequent deep venous and arterial thrombotic events remains unknown.We examined this in a nationwide population-based setting duringa periodwhenSVT was not treated routinely with anticoagulants. TheDanish National Registry of Patients, covering all Danish hospitals, was used to identify 10 973 patientswith a first-time diagnosis of SVT between 1980 and 2012. A comparison cohort of 515 067 subjects, matched by age, gender, and calendar year, was selected from the general Danish population. Outcomes were venous thromboembolism, acute myocardial infarction, ischemic stroke, and death. Duringmedian follow-up of 7 years, the incidence rate of venous thromboembolismwas 18.0/1000 person-years (95%confidence interval [CI], 17.2-18.9). The highest risk occurred in the first 3 months (3.4%; 95% CI, 3.0-3.7). Comparedwith thegeneral population, thehazard ratio was 71.4 (95%CI, 60.2-84.7) in this period, steadily decreasing to 5.1 (95% CI 4.6-5.5), 5 years after the SVT. The hazard ratios for acute myocardial infarction, stroke, and death were 1.2 (95% CI, 1.1-1.3), 1.3 (95% CI, 1.2-1.4), and 1.3 (95% CI, 1.2-1.3), respectively, with the highest risk also shortly after SVT. These data indicate the prognostic importance of SVT and may form the basis for clinical decisionmaking regarding anticoagulation.
ASJC Scopus subject areas
- Cell Biology